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Abstract 
The distribution of fatty acids among cellular glycerophospholipids is finely regulated 
by the CoA-dependent acylation of lysophospholipids followed by transacylation 
reactions. Arachidonic acid is the fatty acid precursor of  a wide family of bioactive 
compounds called the eicosanoids, with key roles in innate immunity and inflammation. 
Because availability of free AA constitutes a rate-limiting step in the generation of 
eicosanoids by mammalian cells, many studies have been devoted to characterize the 
processes of arachidonate liberation from phospholipids by phospholipase A2s and its 
re-incorporation and further remodeling back into phospholipids by acyltransferases and 
transacylases. These studies have traditionally been conducted by using radioactive 
precursors which do not allow the identification of the phospholipid molecular species 
involved in these processes. Nowadays, lipidomic approaches utilizing mass 
spectrometry provide a new frame for the analysis of unique phospholipid species 
involved in fatty acid release and phospholipid incorporation and remodeling. This 
review  focuses on the mass spectrometry techniques applied to the study of 
phospholipid fatty acid trafficking and the recent advances that have been achieved by 
the use of this technique. 
 
 
Abbreviations: AA, arachidonic acid; GP, glycerophospholipid; PLA2, phospholipase 
A2; cPLA2, cytosolic group IVA PLA2; iPLA2, Ca2+-independent PLA2; sPLA2, secreted 
PLA2; ACS, acyl-CoA synthetase; LPCAT, lysophosphatidylcholine:acyl-CoA 
acyltransferase; ESI, electrospray ionization; HPLC, high performance liquid 
chromatography, MS, mass spectrometry; TLC, thin layer chromatography. 
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1. Introduction 
Once regarded as mere building blocks or as energy-storage depots, lipids are now 
universally recognized to play key roles in cell communication and a number of 
physiological and pathophysiological states [1-8]. Among the various lipid families are 
the fatty acids, which are frequently found esterified in the sn-1 and sn-2 positions of 
the glycerol backbone of glycerophospholipids (GPs). Interestingly, saturated fatty acids 
are primarily found in the sn-1 position, whereas unsaturated fatty acids are primarily 
esterified in the sn-2 position [9]. This particular distribution of the apolar fatty acid 
chains together with the polar head group bonded to the phosphate provides these 
compounds with an amphiphilic structure that  is essential to bilayer organization of cell 
membranes. Moreover, the distribution of fatty acids in cells is achieved by  a 
controlled movement of incorporation, remodeling and liberation of fatty acids into, 
among and from GPs, respectively [10]. In these three processes, PLA2 enzymes play 
important roles, since they release free fatty acids by cleaving the ester bonds at the sn-2 
position of GPs [11, 12], and help maintain the 2-lysoglycerophospholipid pool that acts 
as free fatty acid acceptor for further remodeling reactions [13, 14].  
Mammalian PLA2 enzymes involved in long-chain fatty acid metabolism have 
frequently been classified into three groups according to biochemical commonalities, 
namely, Ca2+-independent cytosolic PLA2 (iPLA2), Ca2+-dependent cytosolic PLA2 
(cPLA2), and Ca2+-dependent secreted PLA2 (sPLA2) [11, 12]. The role of  iPLA2 in 
phospholipid fatty acids homeostasis has been thoroughly studied, and appears to be 
strikingly dependent on cell type [15-23]. When the cells are stimulated via surface 
receptors, cPLA2 becomes a major regulator of  phospholipid fatty acid turnover. cPLA2 
is regulated at a cellular level by mitogen-activated protein kinase-mediated 
phosphorylation cascades and by Ca2+ transients, which induces translocation of the 
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enzyme to various organelles, to initiate phospholipid hydrolysis and free fatty acid 
release [23-30]. In activated cells, particularly those of immunoinflammatory origin, a 
sPLA2 may also participate in stimulated phospholipid hydrolysis by acting in concert 
with cPLA2 [31-33]. 
Due to the importance of AA in inflammation, the trafficking of this fatty acid in 
cells involved in immunoinflammatory reactions (e.g. phagocytes, mast cells) has been 
thoroughly studied [34]. In these cells, free AA usually incorporates in phospholipids, 
mainly PC,  via the Lands cycle of phospholipid deacylation/reacylation by the action of 
an acyl-CoA lysoglycerophosphocholine acyltransferase (LPCAT) [34]. Next,  the AA 
is transferred in a remodeling process [34] from PC to PE by the action of CoA-
independent transacylase (CoA-IT). In these two steps, PLA2 enzymes, particularly 
iPLA2, play regulatory roles by maintaining the levels of 2-lyso acceptors [13, 14, 35, 
36]; lysoPC as a transient acceptor, and lysoPE as a final acceptor (Fig. 1). The process 
of CoA-IT AA remodeling is a key regulatory point in the AA trafficking mechanism 
because blockade of this enzyme has been associated to induction of apoptosis [37, 38].  
Traditional studies on the remodeling of glycerophospholipid fatty acids have 
been carried out by incubating the cells with a radiolabeled fatty acid, extraction of the 
sample, separation of GP classes by TLC and quantification by scintillation counting. 
Using this methodology, determination of the particular species within every GP class is 
achieved through a laborious protocol that may involve derivatization and multiple 
separation steps before final quantification by scintillation counting [39, 40]. Current 
advances in the coupling of mass spectrometry to liquid chromatography through 
electrospray ionization (ESI), as well as the development of MS tandem triple 
quadrupole analyzers have made the high-throughput analysis of GPs possible. This 
breakthrough is not only quantitative, but also qualitative, leading to the emergence of  
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a new field called lipidomics [41-43]. Lipidomics is not solely focused towards analysis 
and chemometrics, but aims at the knowledge of lipid changes and their interacting 
partners in a biological context [44-46]. In addition, the term metabolipidomics has 
been coined to emphasize the dynamical aspects of lipids in cells, organs, tissues and 
whole organisms, as lipidomics is focused on profiling the "static" composition of 
molecular species in biological samples [47]. As the main tool for metabolipidomics is 
stable isotope labeling, this strategy takes advantage of the previous radiolabeling 
studies in addition to the MS analysis capability, thus making it possible the 
identification of minor species with rapid turnover rates that may be involved in 
phospholipid fatty acid remodeling [48]. 
 
 
2. Mass spectrometry approaches to the study of phospholipid fatty 
acid remodeling 
Preparation of the samples for MS analysis will generally require liquid-liquid 
extraction, evaporation of the organic extract under vacuum or a nitrogen stream, and 
resuspension in a proper solvent mix. Historically, the most widely used extraction 
methods for GPs are the chloroform-based method of Bligh and Dyer for cell samples 
[49] and the Folch method for tissue samples [50]. 
Taking into account the technical developments of MS and the structure of GPs, 
two main strategies for the study of fatty acid remodeling can be used. The first strategy 
combines the direct infusion to the ESI chamber of the resuspended lipid extract with 
the use of precursor ion scanning of characteristic ions in fragmentation experiments 
(ESI-MS/MS) [51, 52]. The mass spectrometry analyzer used in precursor ion scanning 
is the triple quadrupole. The first quadrupole scans the range of m/z for GPs; in the 
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second chamber the ions selected in the previous one are fragmented by collision-
induced dissociation (CID), and the third quadrupole transmits a fragment with a 
specific m/z, so that the ions isolated in the first quadrupole that yield a specific 
fragment are the only ones to be detected [53, 54]. Therefore, direct infusion and 
precursor ion scanning procedures are suitable for analyzing families of compounds 
whose m/z values corresponding to the precursor ion are different but  share a common 
structural part and, therefore, render a common identifying fragment (Table 1). For 
instance, when the ionization is carried out in positive mode, all PC species, whose m/z 
in MS depends on the acyl substituents (number of carbon atoms and double bonds), 
have the phosphocholine unit that yields m/z 184 in CID; hence, if m/z 184 is fixed in 
the third quadrupole and different m/z are filtered in the first one, the species with a 
phosphocholine unit but different acyl chains can be detected [55, 56]. Similarly, 
families of compounds can be characterized in CID by a specific neutral loss (NL). In 
such analysis,  the first quadrupole and the third quadrupole must be in scan mode but 
coupled with the NL difference of m/z.  
The strategy described above is quite straightforward and not too time- or 
solvent-consuming. However, a major problem is that, inasmuch as the mass 
information obtained corresponds to the sum of carbons and double bonds of the two 
fatty acids initially present, it is not possible to unequivocally identify the fatty acids 
present in each GP. An additional drawback of this procedure is that complex matrix 
effects can produce ion suppression and the signal of minor species can be lost.  
By using the scheme of serial product ion scanning (ESI-MS/MS) [53], the 
length and double bonds of both acyl chains present in a GP can be determined by 
quadrupole-time of flight (q-ToF) mass spectrometry. However, in these spectrometers,  
ion suppression in direct infusion analysis can still eliminate minor signals of GPs. On 
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the other hand, triple quadrupole instruments achieve a better performance than q-TOF 
instruments for quantifying purposes. 
In order to obtain more accurate structural information and to minimize matrix 
effects, a second strategy has been developed which consists in introducing a step of 
separation before MS detection, by coupling an HPLC instrument to the MS instrument. 
Separation of GPs by HPLC can be carried out by using two stationary phases, namely 
normal phase (NP) and reversed phase (RP) [57]. In normal phase, where molecules 
interact with a polar stationary phase --typically silica gel [58] or diol-modified columns 
[59]--, GPs are primarily separated by their polar headgroup, the less polar compounds 
eluting first and the most polar eluting later. Reversed phase liquid chromatography 
consists of silica coated  with hydrocarbon chains --typically ocadecyl and octyl [60-
62]-- and, since the stationary phase is apolar, GPs are primarily retained and separated 
by acyl chains, eluting first those with less number of carbons and more double bonds 
[63]. This implies that GPs belonging to the same class (the same polar headgroup) and 
producing the same m/z but containing different acyl chains, can be separated by this 
procedure (e.g., PE(18:0/18:0) and PE(P-18:2/20:4)).  
Coupling of HPLC with mass spectrometry has been mostly done with an ESI 
interface and, with regard to ion separation, several analyzer types have been used [57]. 
Ion-traps have been used in full scan mode (HPLC-ESI-MS) [60, 64]. In this type of MS 
analysis, analyzer saturation problems are avoided by the previous chromatographic 
separation step. Quadrupole analyzers have been used both in multiple reaction 
monitoring (HPLC-ESI-MS/MS) with triple quadrupole spectrometers [65, 66], and in 
full scan with single quadrupole spectrometers (HPLC-ESI-MS) [67]. Although ion-
traps are not suitable for MS/MS quantification analysis, they offer the possibility of 
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performing more than one cycle of fragmentation, which permits in-depth structural 
characterization [68].  
 Both NP and RP-HPLC offer a good separation and avoid putative analytical 
interferences. However, since GPs co-elute by polar headgroup in NP-HPLC, this mode 
offers the same analytical information as direct infusion with precursor ion scanning. 
When minor compounds and/or specific species analysis is required, RP-HPLC is the 
preferred separation technique. Notwithstanding, while good separation of PE, PC and 
PI is possible in RP-HPLC, PA and PS show high-grade peak tailings that frequently 
prevent quantification.  Important improvements in the separation and analysis of PA 
and PS have recently been reported [69]. 
To conclude this section, the analytical strategy to be utilized, namely ESI-
MS/MS or HPLC-ESI-MS/MS depends on the aim pursued. A summary of choices is 
depicted as a flowchart in Fig. 2. 
 
 
3. Research Applications: PLA2-regulated Phospholipid Fatty Acid 
Trafficking 
Two different approaches can be undertaken to study  the remodeling of GP fatty acids 
by MS. The first one focuses on the polar headgroup and addresses the variation of 
apolar chains. The second approach deals with variations of the apolar chains among 
defined GP classes. Both approaches may take advantage of the use of stable isotope-
labeled compounds (metabolipidomics) to study the pathways of incorporation/ 
remodeling of a specific fatty acid or headgroup.  
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3.1. Headgroup-based studies 
In these studies the aim is to analyze the recycling of fatty acids within a specific GP 
class (same headgroup). Thus, precursor ion scanning of headgroup-containing specific 
fragments appears as the most straightforward approach  
By using tandem MS, Rouzer et al. studied GP fatty acid remodeling in murine 
resident peritoneal macrophages and RAW264.7 cells stimulated with yeast-derived 
zymosan  [70].  A deficiency of AA in cultured cells as compared to their primary 
counterparts was evidenced, and AA-supplemented RAW264.7 cells showed a 
distribution of AA among GPs that was different from that found in resident murine 
macrophages [70]. Moreover, when the  macrophages were exposed to zymosan, which 
activated cPLA2,  AA-containing PC species were found to act as net donors of  the 
cPLA2–mediated free AA mobilization, and AA-containing PE species did not show 
significant changes [71].  
To specifically study those GPs that have been recently synthesized, a 
metabolipidomic approach can be followed by incubating the cells with a stable isotope-
containing compound that labels the polar headgroup of certain phospholipids. In these 
samples, precursor ion scanning of headgroup-derived  fragments in tandem MS would 
be the technique of choice. For example, addition of [2H]9-choline to the cells would 
generate newly synthesized [2H]-labeled PC which could be identified by  ESI-MS/MS 
scan of m/z 193 in positive mode. Since the fragment of 184 corresponds to endogenous 
PC, it would be possible to compare the composition of newly-synthesized PC with that 
of pre-existing PC. Such an approach has recently been carried out by Postle et al. [72] 
to compare the composition and dynamic remodeling of endonuclear GP species in 
cultured cells. Experiments with alternative MS/MS precursor scans of 184 and 193 in 
positive mode when IMR32 neuroblastoma cells are exposed to [2H]9-choline, revealed 
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a higher grade of saturation of PC in the endonuclear space, which  remodels with time 
into an even more saturated profile [73]. In addition, the profile of GPs in whole cells in 
the equilibrium was found to be more sensitive to culture conditions than endonuclear 
GPs. These latter showed a highly regulated synthesis and remodeling of acyl chains in 
the endonuclear compartment [74]. 
Using a similar metabolipidomic technique, two newly-synthesized different 
pools of PC have been described in yeast [75]. A pool comes from PE methylation and 
can be characterized by labeling with (methyl-[2H]3)-methionine, whereas the other one 
comes from the de novo route. None of the two newly synthesized PC sources matches 
the PC profile in the equilibrium, suggesting that a remodeling process via PLA is 
necessary  [75]. 
Another approximation to the study of fatty acid remodeling is the one described 
recently by Kainu et al. [76], where  a whole GP, labeled in the headgroup, is 
introduced in the cell by a cyclodextrin-based shuttling procedure. Using this approach, 
the remodeling of acyl chains at both sn-1 and sn-2 positions was characterized in PE 
and PS in BHK21 and HeLa cell lines. When the exogenous GP had a fatty acid 
composition not originally present in the cell, the remodeling process was carried out 
very quickly, to ultimately reach a fatty acid composition similar to that existing in the 
endogenous headgroup counterparts [76]. Conversely, when the exogenous GP had a 
fatty acid composition already present in the cell, remodeling was rather slow [76]. By 
double-labeling both headgroup and sn-2 fatty acid of the exogenously-added GP, it was 
found that the extent of remodeling was directly related to the extent of PLA2-mediated 
hydrolysis on this particular GP. Based on the finding that  that PE and PS species with 
identical acyl chain composition remodeled at different rates, the possibility was 
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suggested that the PLA2 enzymes involved were able to discriminate not only among 
fatty acid residues, but also among headgroups [76]. 
 
3.2. Fatty acid-based studies 
To study the recycling of a particular fatty acid, MS/MS precursor ion scanning 
experiments would constitute the most straightforward approach. For example, 
remodeling of AA can be studied by scanning the precursor ions of m/z 303 in negative 
mode. It is important to note that when labeled fatty acids are used, interferences of 
endogenous fatty acids with the same m/z may occur. Commercial deuterium-labeled 
AA contains eight deuterium atoms ([2H]8AA). Thus the m/z  to carry out the precursor 
ion scan in negative mode is 311. Unfortunately, arachidic acid (C20:0) produces the 
same m/z in tandem MS detection. This could be a major problem when studying GP 
species enriched in both arachidic and AA, e.g  PE. Since these two fatty acids notably 
differ in the number of double bonds (0 vs 4, respectively), a manner to circumvent this 
problem would be to conduct a RP-HPLC separation step before MS analysis.  
 By using RP-HPLC-ESI-MS and deuterium-labeled AA, we have recently 
identified the PI species involved in the initial incorporation of AA in human monocytes 
and U937 cells [48]. Four major species were identified, namely PI(16:0/[2H]AA), 
PI(18:1/[2H]AA), PI(18:0/[2H]AA) and PI([2H]AA/[2H]AA). Pulse-labeling with 
[2H]AA for short periods of time and monitoring of these species in monocyte-like 
U937 cells, showed that the levels of PI([2H]AA/[2H]AA) experience an exponential 
decrease, disappearing within three hours. In contrast, the levels of the other [2H]AA-
containing PI molecular species decrease only slightly with time [48].  
Stimulation of the monocytes with the phagocytosable stimulus zymosan, 
activates cPLA2,  which results in extensive recycling of AA among GPs. We have used 
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RP-HPLC-ESI-MS to track these changes and, consistent with previous studies [71], we 
have found that all major AA-containing PC and PI species show a decrease that is 
cPLA2-dependent, but AA-containing PE major species do not show significant 
variation (Balgoma et al., manuscript in preparation). In addition, these studies have 
allowed us to identify three minor species that, unlike all other species, increase rather 
than decrease after cellular activation. Two of the three species are PC(20:4/20:4) and 
PI(20:4/20:4),  are apparently produced in a deacylation/reacylation pathway via cPLA2 
and acyl-CoA synthetase-dependent reactions. The third minor species, PE(16:1/20:4), 
is undetectable in unstimulated cells and may be produced via coenzyme A-independent 
transacylation reactions (Balgoma et al., manuscript in preparation). 
 
4. Concluding remarks 
Mass spectrometry offers selectivity and sensitivity to study fatty acid remodeling 
within individual GP species and the role of PLA2 in this process. The analytical 
method to utilize,  i.e. ESI-MS/MS or HPLC-ESI-MS/MS, will depend on the 
information that is desired to obtain.  
Since  AA is found primarily in the sn-2 position of GPs, PLA2 enzymes are key 
regulators of phospholipid AA incorporation and remodeling. PLA2 enzymes may act 
on various points in the remodeling process of AA; by acting upon GPs and liberating 
free AA, and indirectly by producing lysoPC and lysoPE that act as transient and final 
acceptors of AA. The use of  RP-HPLC-ESI-MS  in the study of AA incorporation and 
remodeling has allowed the detection of minor species in human monocytes, namely 
PC(20:4/20:4), PE(16:1/20:4) and PI(20:4/20:4) which are generated as specific 
products of fatty acid remodeling reactions. Thus, mass spectrometry lipidomics 
approaches allow the possibility of studying the process of fatty acid remodeling in 
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depth, with emphasis on the differential remodeling of the sn-1 and sn-2 positions of the 
glycerol backbone, even when both positions are esterified by the same fatty acid.  
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Figure Legends  
 
Figure 1. Dual role of PLA2 enzymes in glycerophospholipid AA incorporation and 
remodeling 
 
Figure 2. Flowchart  to choose the appropriate analytical strategy to study fatty acid 
remodeling by PLA2. Metabolipidomics refers to MS experiments with stable isotope 
labeled compounds. 
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Table 1. 
Specific fragments produced by glycerophospholipid classes depending on phosphate 
linked polar head group in MS/MS experiments 
GP class Precursor ion  Identifying fragment 
PA [M-H]-  m/z 153 
PI [M-H]-  m/z 241 
PIP [M-H]-  m/z 321 
PIP2 [M-H]-  m/z 401 
PS [M-H]-  NL 87 
PE [M-H]-  m/z 196 
PC [M+H]+  m/z 184 
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